Your browser doesn't support javascript.
loading
Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy.
Mhatre, Radhika; Sekar, Deepha; Ponmalar, Jessiena; Nagappa, Madhu; Veeramani, Preethish-Kumar; Polavarapu, Kiran; Vengalil, Seena; Atchayaram, Nalini; Narayanappa, Gayathri.
Affiliation
  • Mhatre R; Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Sekar D; Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Ponmalar J; Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Nagappa M; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Veeramani PK; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Polavarapu K; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Vengalil S; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Atchayaram N; Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Narayanappa G; Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Ann Indian Acad Neurol ; 24(2): 198-203, 2021.
Article in En | MEDLINE | ID: mdl-34220063
OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (α2, α5,ß1,γ1), Collagen-VI (A1,2,3), and Western blot (WB) for α-dystroglycan and POMT1 was performed. RESULTS: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-α2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-ß1, over-expression of laminin-α5, and preserved laminin-γ1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for α-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-α2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker-Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. CONCLUSION: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Indian Acad Neurol Year: 2021 Document type: Article Affiliation country: India Country of publication: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Indian Acad Neurol Year: 2021 Document type: Article Affiliation country: India Country of publication: India